We’re on a near-term path to achieving nuclear fusion energy at a low enough cost to replace all fossil-fuel based energy sources and end fossil fuel use. We will harness the energy source that powers the sun to create clean, safe energy. If we secure the funding to complete our project, this will be the most fundamental change in technology in decades. It will flip the power from fossil to fusion.
Eric J. Lerner President and Chief Scientist @ LPPFusion
Announcement on end of capital round Dec 31:
Based on the progress that we have made with the project and on our improving prospect for raising more capital, the LPPFusion Board of Advisors on Nov. 30 decided, without dissent, that we will be closing the present capital round Dec. 31 and starting another round next year at a higher price of $150/share. (The present price is $125/share.) Several shareholders at our Annual Shareholders Meeting and via email had urged a price increase and the Board has agreed.
Since the last price increase five years ago, we have raised just over $3 million. During that time, we have increased our Focus Fusion device’s fusion yield, achieving:
- the highest ratio of fusion yield to input energy of any private fusion effort,
- the highest confined ion temperatures of any fusion device, and
- the highest level of purity in our plasma,
thanks to our beryllium electrodes. In the past year, we have designed and have begun assembling improved switches and are far along in our redesign of our anode and external circuit. You will be hearing more about this during December. We feel that these advances reduce the risk of our project and amply justify a 20% increase in price.
With 313,484 shares outstanding, this increases the LPPFusion valuation to $47 million.
Right now, our capital round is only open to accredited investors. For those of you who are accredited, this is your last chance to buy LPPFusion shares at $125/share.
LPPFusion is a privately-held “C” corporation incorporated in NJ in 2003. LPP is short for Lawrenceville Plasma Physics.
LPPFusion was granted a comprehensive U.S. Patent #7,482,607 and international patents:
- Australian Patent 2007314648 issued November 2011
- Chinese patent, 200780007065.7 issued December, 2012
- Canadian Patent, 2,642,749 issued December, 2015
- European Union Patent EP 1989714B1 issued April, 2018
- Still pending in India.
Our Massive Cost Advantage
LPPFusion has raised over $7M from over 500 private investors and one Institutional Investor. Accredited U.S. and foreign investors can purchase Class B, non-voting shares. We have successfully closed five equity rounds. Our current round should fund us to Net Energy and allow us to develop our spin-off X-scan technology for the Homeland Security market.
Today, investments in LPPFusion can only be made by foreign and accredited U.S. investors (e.g. investors with net worth in excess of $1M, or income exceeding $200K), as defined in Rule 506(c) of Regulation D of the Securities Act of 1933. Non-accredited investors can sign up here to get on our mailing list in case we do another round of crowdfunding.
Financial Audit Reports
. . . . .
This web page is not intended to be an offer of securities to the residents of any state, nor is it an offer otherwise specifically directed to any person in any state by, or on behalf of, Lawrenceville Plasma Physics, Inc DBA LPPFusion. Any forward-looking statements are based on the beliefs of LPPFusion’s management and reflect current expectations at the time the statements are made with respect to future events based on information available at that time, and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in those forward-looking statements.